1 李莉, 姜玉新, 乌正, 等. 高血压及心脑血管疾病与颈动脉粥样硬化[J ]. 中华心血管病杂志, 1996,24:126-129.2 中华神经科学会, 中华神经外科学会. 各类脑血管病诊断要点及脑卒中患者临床神经功能缺损程度评分标准[J]. 中华神经科杂志, 1996, 29:379-381.3 智光, 主编. 冠状动脉粥样硬化性心脏病超声诊断学[M]. 北京: 人民军医出版社, 2001:131-132.4 Sawayama Y, Shimizu C, Maeda N, et al. Effectsof probucol and pravastatin on common carotidatherosclerosis in patients with asymptomatichypercholesterolemia:Fukuoka atherosclerosis trial(FAST)[J]. J Am Coll Cardiol, 2002, 39:610-616.5 董怡, 华秀云. 颈动脉斑块的超声表现与神经血管症状[J]. 中国临床神经科学, 2002, 10:205-207.6 Wada T, Louhelainen J, Hemminki K, et al. Theprevalence of loss of heterozygosity in chromosome3, including FHIT, in bladder cancer, using thefluorescent multiplex polymerase chain reaction[J].BJU Int, 2001, 87:876-881.7 Baffa R, Gomella LG, Vecchione A, et al. Loss ofFHIT expression intransitional cell carcinoma of theurinary bladder[J]. Am J Pathol, 2000, 156:419-424.8 Bots ML, Elwood PC, Salonen JT, et al. Level offibrinogen and risk of fatal and non-fatal stroke.EUROSTROKE:a collaborative study among researchcentres in Europe[J]. J Epidemiol Community Health,2002, 56:i14-i18.9 Fukujima MM, Ma r t inez TL, Pinto LE, et al.Fibrinogen as independent risk factor for ischemicstroke[J]. Arq Neuropsiquiatr, 1997, 55:737-740.10 Moons KGM, Bots ML, Salonen JT, et al. Predictionof st roke in the general population in Europe(EUROSTROKE): Is there a role for fibrinogen andelectrocardiography?[J]. J Epidemiol CommunityHealth, 2002, 56:i30-i36.11 曹勇军, 吴延华, 刘春风. 纤维蛋白(原)及其降解产物对共培养血管内皮细胞tPA和PAI-1表达的影响[J]. 中华心血管病杂志, 2008, 36:62-67.12 曹勇军, 钱进军, 刘春风. 纤维蛋白(原)、纤维蛋白(原)降解产物及基序拮抗剂与动脉粥样硬化[J]. 国际脑血管病杂志, 2006, 14:290-293.13 吴延华, 曹勇军, 刘春风. 组织型纤溶酶原激活物及其抑制剂与动脉粥样硬化的关系[J]. 国际脑血管病杂志,2007, 15:534-537.14 Ageno W, Fina z z i S, St eidl L, et al. Pla smameasurement of D-dimer levels for the early diagnosisof ischemic stroke subtypes[J]. Arch Intern Med,2002, 162:2589-2593. |